Cargando…

A randomized controlled trial of daily sedation interruption in critically ill children

PURPOSE: To compare daily sedation interruption plus protocolized sedation (DSI + PS) to protocolized sedation only (PS) in critically ill children. METHODS: In this multicenter randomized controlled trial in three pediatric intensive care units in the Netherlands, mechanically ventilated critically...

Descripción completa

Detalles Bibliográficos
Autores principales: Vet, Nienke J., de Wildt, Saskia N., Verlaat, Carin W. M., Knibbe, Catherijne A. J., Mooij, Miriam G., van Woensel, Job B. M., van Rosmalen, Joost, Tibboel, Dick, de Hoog, Matthijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726735/
https://www.ncbi.nlm.nih.gov/pubmed/26602782
http://dx.doi.org/10.1007/s00134-015-4136-z
_version_ 1782411878103777280
author Vet, Nienke J.
de Wildt, Saskia N.
Verlaat, Carin W. M.
Knibbe, Catherijne A. J.
Mooij, Miriam G.
van Woensel, Job B. M.
van Rosmalen, Joost
Tibboel, Dick
de Hoog, Matthijs
author_facet Vet, Nienke J.
de Wildt, Saskia N.
Verlaat, Carin W. M.
Knibbe, Catherijne A. J.
Mooij, Miriam G.
van Woensel, Job B. M.
van Rosmalen, Joost
Tibboel, Dick
de Hoog, Matthijs
author_sort Vet, Nienke J.
collection PubMed
description PURPOSE: To compare daily sedation interruption plus protocolized sedation (DSI + PS) to protocolized sedation only (PS) in critically ill children. METHODS: In this multicenter randomized controlled trial in three pediatric intensive care units in the Netherlands, mechanically ventilated critically ill children with need for sedative drugs were included. They were randomly assigned to either DSI + PS or PS only. Children in both study arms received sedation adjusted on the basis of validated sedation scores. Provided a safety screen was passed, children in the DSI + PS group received daily blinded infusions of saline; children in the PS group received blinded infusions of the previous sedatives/analgesics. If a patient’s sedation score indicated distress, the blinded infusions were discontinued, a bolus dose of midazolam was given and the ‘open’ infusions were resumed: DSI + PS at half of infusion rate, PS at previous infusion rate. The primary endpoint was the number of ventilator-free days at day 28. Data were analyzed by intention to treat. RESULTS: From October 2009 to August 2014, 129 children were randomly assigned to DSI + PS (n = 66) or PS (n = 63). The study was terminated prematurely due to slow recruitment rates. Median number of ventilator-free days did not differ: DSI + PS 24.0 days (IQR 21.6–25.8) versus PS 24.0 days (IQR 20.6–26.0); median difference 0.02 days (95 % CI −0.91 to 1.09), p = 0.90. Median ICU and hospital length of stay were similar in both groups: DSI + PS 6.9 days (IQR 5.2–11.0) versus PS 7.4 days (IQR 5.3–12.8), p = 0.47, and DSI + PS 13.3 days (IQR 8.6–26.7) versus PS 15.7 days (IQR 9.3–33.2), p = 0.19, respectively. Mortality at 30 days was higher in the DSI + PS group than in the PS group (6/66 versus 0/63, p = 0.03), though no causal relationship to the intervention could be established. Median cumulative midazolam dose did not differ: DSI + PS 14.1 mg/kg (IQR 7.6–22.6) versus PS 17.0 mg/kg (IQR 8.2–39.8), p = 0.11. CONCLUSION: In critically ill children, daily sedation interruption in addition to protocolized sedation did not improve clinical outcome and was associated with increased mortality compared with protocolized sedation only.
format Online
Article
Text
id pubmed-4726735
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-47267352016-02-02 A randomized controlled trial of daily sedation interruption in critically ill children Vet, Nienke J. de Wildt, Saskia N. Verlaat, Carin W. M. Knibbe, Catherijne A. J. Mooij, Miriam G. van Woensel, Job B. M. van Rosmalen, Joost Tibboel, Dick de Hoog, Matthijs Intensive Care Med Pediatric Original PURPOSE: To compare daily sedation interruption plus protocolized sedation (DSI + PS) to protocolized sedation only (PS) in critically ill children. METHODS: In this multicenter randomized controlled trial in three pediatric intensive care units in the Netherlands, mechanically ventilated critically ill children with need for sedative drugs were included. They were randomly assigned to either DSI + PS or PS only. Children in both study arms received sedation adjusted on the basis of validated sedation scores. Provided a safety screen was passed, children in the DSI + PS group received daily blinded infusions of saline; children in the PS group received blinded infusions of the previous sedatives/analgesics. If a patient’s sedation score indicated distress, the blinded infusions were discontinued, a bolus dose of midazolam was given and the ‘open’ infusions were resumed: DSI + PS at half of infusion rate, PS at previous infusion rate. The primary endpoint was the number of ventilator-free days at day 28. Data were analyzed by intention to treat. RESULTS: From October 2009 to August 2014, 129 children were randomly assigned to DSI + PS (n = 66) or PS (n = 63). The study was terminated prematurely due to slow recruitment rates. Median number of ventilator-free days did not differ: DSI + PS 24.0 days (IQR 21.6–25.8) versus PS 24.0 days (IQR 20.6–26.0); median difference 0.02 days (95 % CI −0.91 to 1.09), p = 0.90. Median ICU and hospital length of stay were similar in both groups: DSI + PS 6.9 days (IQR 5.2–11.0) versus PS 7.4 days (IQR 5.3–12.8), p = 0.47, and DSI + PS 13.3 days (IQR 8.6–26.7) versus PS 15.7 days (IQR 9.3–33.2), p = 0.19, respectively. Mortality at 30 days was higher in the DSI + PS group than in the PS group (6/66 versus 0/63, p = 0.03), though no causal relationship to the intervention could be established. Median cumulative midazolam dose did not differ: DSI + PS 14.1 mg/kg (IQR 7.6–22.6) versus PS 17.0 mg/kg (IQR 8.2–39.8), p = 0.11. CONCLUSION: In critically ill children, daily sedation interruption in addition to protocolized sedation did not improve clinical outcome and was associated with increased mortality compared with protocolized sedation only. Springer Berlin Heidelberg 2015-11-24 2016 /pmc/articles/PMC4726735/ /pubmed/26602782 http://dx.doi.org/10.1007/s00134-015-4136-z Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Pediatric Original
Vet, Nienke J.
de Wildt, Saskia N.
Verlaat, Carin W. M.
Knibbe, Catherijne A. J.
Mooij, Miriam G.
van Woensel, Job B. M.
van Rosmalen, Joost
Tibboel, Dick
de Hoog, Matthijs
A randomized controlled trial of daily sedation interruption in critically ill children
title A randomized controlled trial of daily sedation interruption in critically ill children
title_full A randomized controlled trial of daily sedation interruption in critically ill children
title_fullStr A randomized controlled trial of daily sedation interruption in critically ill children
title_full_unstemmed A randomized controlled trial of daily sedation interruption in critically ill children
title_short A randomized controlled trial of daily sedation interruption in critically ill children
title_sort randomized controlled trial of daily sedation interruption in critically ill children
topic Pediatric Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726735/
https://www.ncbi.nlm.nih.gov/pubmed/26602782
http://dx.doi.org/10.1007/s00134-015-4136-z
work_keys_str_mv AT vetnienkej arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT dewildtsaskian arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT verlaatcarinwm arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT knibbecatherijneaj arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT mooijmiriamg arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT vanwoenseljobbm arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT vanrosmalenjoost arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT tibboeldick arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT dehoogmatthijs arandomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT vetnienkej randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT dewildtsaskian randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT verlaatcarinwm randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT knibbecatherijneaj randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT mooijmiriamg randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT vanwoenseljobbm randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT vanrosmalenjoost randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT tibboeldick randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren
AT dehoogmatthijs randomizedcontrolledtrialofdailysedationinterruptionincriticallyillchildren